Published in

Taylor and Francis Group, Expert Opinion on Drug Safety, 5(16), p. 573-585, 2017

DOI: 10.1080/14740338.2017.1313228

Links

Tools

Export citation

Search in Google Scholar

Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer

Distributing this paper is prohibited by the publisher
Distributing this paper is prohibited by the publisher

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO